Yujun Dong
Overview
Explore the profile of Yujun Dong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
215
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yang X, Zhu J, Wang Q, Tang B, Shen Y, Wang B, et al.
mSystems
. 2024 May;
9(6):e0138523.
PMID: 38752789
Importance: A majority of previous studies focused on the characterization of coronavirus infectious disease 2019 (COVID-19) disease severity in people with normal immunity, while the characterization of COVID-19 in immunocompromised...
12.
Zhang Y, Deng Y, Zou Q, Jing B, Cai P, Tian X, et al.
Cell Rep Med
. 2024 May;
5(5):101551.
PMID: 38697104
Accurate diagnosis and prognosis prediction are conducive to early intervention and improvement of medical care for natural killer/T cell lymphoma (NKTCL). Artificial intelligence (AI)-based systems are developed based on nasopharynx...
13.
Yang X, Wuchty S, Liang Z, Ji L, Wang B, Zhu J, et al.
Brief Bioinform
. 2024 Jan;
25(2).
PMID: 38279649
The identification of human-herpesvirus protein-protein interactions (PPIs) is an essential and important entry point to understand the mechanisms of viral infection, especially in malignant tumor patients with common herpesvirus infection....
14.
Wang L, Gao L, Liang Z, Cen X, Ren H, Dong Y
Leuk Lymphoma
. 2023 Dec;
65(3):353-362.
PMID: 38069781
Unfit acute myeloid leukemia and high-risk myelodysplastic syndrome patients with prolonged neutropenia demand coadministration of venetoclax and azoles. However, venetoclax dosing under drug-drug interaction with azoles remains controversial. Therapeutic drug...
15.
Zhai Y, Wang Q, Ji L, Ren H, Dong Y, Yang F, et al.
Cancer Med
. 2023 Dec;
12(24):21592-21604.
PMID: 38062912
Background: Chromosomal translocations involving core binding factor (CBF) genes account for 15% of adult acute myeloid leukemia (AML) cases in China. Despite being classified as favorable-risk by European Leukemia Net...
16.
Zhu J, Wang Q, Ren H, Dong Y, Yin Y, Wang Q, et al.
Front Immunol
. 2023 Nov;
14:1274492.
PMID: 37928518
Background: The widespread adoption of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT) has significantly improved the survival rates of patients with hematological malignancies. However, Graft-Versus-Host Disease (GVHD) remains a formidable complication,...
17.
Guo M, Nong L, Wang M, Zhang Y, Wang L, Sun Y, et al.
Ann Hematol
. 2023 Sep;
103(1):153-162.
PMID: 37749319
The purpose is to ascertain the clinical impact of Castleman disease (CD) by reassessment of the real-world data from Peking University First Hospital (PKUFH). The results will contribute to the...
18.
Xiong W, Yu Y, Sun C, Du J, Cai Z, Wang Z, et al.
Haematologica
. 2023 Sep;
109(2):666-670.
PMID: 37706332
No abstract available.
19.
Wu M, Wang F, Zhao S, Li Y, Huang W, Nie B, et al.
Ann Hematol
. 2023 Sep;
102(11):3185-3193.
PMID: 37700194
The aim of this study is to evaluate the survival benefit of consolidative autologous hematopoietic stem cell transplantation (ASCT) in patients with peripheral T-cell lymphomas (PTCL). In this retrospective study,...
20.
Wang Q, Liang Z, Ren H, Dong Y, Yin Y, Wang Q, et al.
Ann Hematol
. 2023 Sep;
102(11):3061-3074.
PMID: 37667046
Acute myeloid leukemia (AML) is a malignant lymphohematopoietic tumor that ranks among the most frequent indications for allogeneic hematopoietic stem cell transplantation (allo-HSCT). This article aims to provide a comprehensive...